Future Medical Device Companies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Future Medical Device Companies

STXS 2.920

-1.7%

Oct 29 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: semi_infinite	2/9/2012 1:33:28 PM
	of 136

Interesting in that V-CAS deflect sounds like a hybrid combination of Stereotaxis Magnetics and Hansen Medical robotic sheath so now there is both mechanical control of catheter steering and tip control using magnets. Neuzil was an early tester and user for both Stereotaxis and Hansen and his comment is especially interesting. V-CAS is 1/3 the cost of the Hansen system. The technology is getting better while both companies struggles in sales. Not sure why STXS market cap is so much less than HNSN. Doesn't seem to make sense from system or disposable revenue comparisons ........ perhaps a arbitrage opp ? >>>>>>>>>>>>>>>>>>> Stereotaxis PR regarding Vdrive initial experience and Canadian fda clearance - finance.yahoo.com The design of the Vdrive system allows the robotic hardware to adapt to different clinical techniques depending on the disposable adaptor that is attached to the arm: V-Loop™ circular catheter manipulator allows control of circular diagnostic catheters, primarily in left atrial procedures.V-CAS™ catheter advancement system allows advancement and retraction of the magnetic catheter as well as robotic manipulation of catheter introducer sheaths that are already in use during the procedure. V-CAS Deflect™ catheter advancement system is a more advanced device that includes an integrated robotic deflectable sheath.Initial positive results from multiple physician users confirmed the significant clinical value delivered by the Vdrive system related to procedure efficiency. Dr. Georg Noelker of the Herz- und Diabeteszentrum NRW in Bad Oeynhausen, Germany commented on the V-Loop system: "We have adopted Vdrive for navigating the circular mapping catheter for all of our left atrial procedures. Our initial experience with Vdrive has shown that we can reduce our left atrial procedures times by approximately 30%, and can further reduce our fluoroscopy times by an additional 14% over our previous times with magnetic navigation alone." Dr. Xu Chen of the Rigshospitalet in Copenhagen commented on the V-CAS system: "The addition of robotic sheath control to a magnetic procedure allows me to efficiently access even challenging areas of the heart chambers and focus on patient therapy instead of catheter control. The Vdrive control was intuitive and did not take long to implement as a part of my procedure. In difficult cases the Vdrive control even reduced my total procedure time."Dr. Petr Neuzil of Homolce Hospital in Prague shared his perspective on the V-CAS Deflect system: "The advancements in the Vdrive technology use the best of previous magnetic and robotic systems to provide a new level of catheter control, which is expected to improve outcomes in ablation procedures."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next